Marwan Sabbagh - Net Worth and Insider Trading

Marwan Sabbagh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marwan Sabbagh owns 2 companies in total, including Quince Therapeutics Inc (QNCX) , and CervoMed Inc (CRVO) .

Click here to see the complete history of Marwan Sabbagh’s form 4 insider trades.

Insider Ownership Summary of Marwan Sabbagh

Ticker	Comapny	Transaction Date	Type of Owner
QNCX	Quince Therapeutics Inc	2022-03-14	director
CRVO	CervoMed Inc	2023-08-16	director

Marwan Sabbagh Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Marwan Sabbagh Ownership Network

Ownership Network List of Marwan Sabbagh

No Data

Ownership Network Relation of Marwan Sabbagh

Marwan Sabbagh Owned Company Details

What does Quince Therapeutics Inc do?

Who are the key executives at Quince Therapeutics Inc?

Marwan Sabbagh is the director of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , Chief Business Officer Brendan Hannah , and President Charles S. Ryan .

Quince Therapeutics Inc (QNCX) Insider Trades Summary

Over the past 18 months, Marwan Sabbagh made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 241,811 shares, with a net purchase of 241,811 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Quince Therapeutics Inc Insider Transactions

No Available Data

Marwan Sabbagh Mailing Address

Above is the net worth, insider trading, and ownership report for Marwan Sabbagh. You might contact Marwan Sabbagh via mailing address: C/o Cortexyme, Inc., 269 East Grand Ave., South San Francisco Ca 94080.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.